MEDX Holdings
34 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 19.14% | 2,654 | $3.2M |
| 2 | AbbVie Inc | 9.99% | 6,068 | $1.6M |
| 3 | US BANK MMDA - USBGFS 7 06/01/2031 | 8.27% | 1,363,568 | $1.4M |
| 4 | Novartis AG | 6.59% | 7,582 | $1.1M |
| 5 | Johnson & Johnson | 5.96% | 3,798 | $981.6K |
| 6 | Amgen Inc | 4.67% | 1,864 | $770.0K |
| 7 | Merck & Co Inc | 4.60% | 5,308 | $757.9K |
| 8 | Alkermes PLC | 4.58% | 18,198 | $754.2K |
| 9 | AstraZeneca PLC | 4.40% | 4,533 | $725.8K |
| 10 | Bristol-Myers Squibb Co | 4.32% | 11,936 | $712.6K |
| 11 | Pfizer Inc | 3.48% | 20,472 | $573.2K |
| 12 | Biogen Inc | 3.32% | 2,464 | $547.4K |
| 13 | Alnylam Pharmaceuticals Inc | 2.67% | 1,960 | $439.8K |
| 14 | CRISPR Therapeutics AG | 2.65% | 8,342 | $436.7K |
| 15 | Ionis Pharmaceuticals Inc | 2.64% | 9,856 | $435.2K |
| 16 | Regeneron Pharmaceuticals Inc | 2.57% | 570 | $423.0K |
| 17 | GSK PLC | 2.54% | 8,900 | $418.5K |
| 18 | Beam Therapeutics Inc | 1.14% | 7,582 | $187.8K |
| 19 | Galectin Therapeutics Inc | 0.93% | 42,452 | $153.7K |
| 20 | Replimune Group Inc | 0.91% | 11,374 | $150.1K |
| 21 | Intellia Therapeutics Inc | 0.81% | 11,374 | $133.2K |
| 22 | Sandoz Group AG (SDZNY) | 0.78% | 1,520 | $129.0K |
| 23 | Haleon PLC | 0.61% | 11,127 | $100.4K |
| 24 | Vanda Pharmaceuticals Inc | 0.57% | 20,472 | $93.4K |
| 25 | Editas Medicine Inc | 0.42% | 25,020 | $68.8K |
Sector Weights
- Healthcare: 100.00%
Country Weights
- United States: 68.93%
- Switzerland: 10.08%
- Other: 8.53%
- United Kingdom: 7.82%
- Ireland: 4.64%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.